AXSM
Axsome Therapeutics, Inc.
Stock
$179.25−2.82 (−1.55%)Close Oct 2, 2026
- Shareholders' equity, 2025
- $88M
- YoY, 2025
- +54.9%
- 5-year CAGR
- −4.9%
- 10-year CAGR
- +6.6%
Shareholders' equity
Shareholders' equity by fiscal year
| Period | Equity | YoY |
|---|---|---|
| 2025 | $88M | +54.9% |
| 2024 | $57M | −70.1% |
| 2023 | $191M | +74.3% |
| 2022 | $110M | +600.9% |
| 2021 | $16M | −86.3% |
| 2020 | $114M | −36.3% |
| 2019 | $179M | +18,955.2% |
| 2018 | $938K | −94.4% |
| 2017 | $17M | −22.5% |
| 2016 | $22M | −53.6% |
| 2015 | $46M | — |
| 2014 | −$3.2M | — |